Abstract:The activation status can dictate the fate of an HIV-infected CD4+ T cell. Infected cells with a low level of activation remain latent and do not produce virus, while cells with a higher level of activation are more productive and thus likely to transfer more virions to uninfected cells during cell-to-cell transmission. How the activation status of infected cells affects HIV dynamics under antiretroviral therapy remains unclear. We develop a new mathematical model that structures the population of infected cells continuously according to their activation status. The effectiveness of antiretroviral drugs in blocking cell-to-cell viral transmission decreases as the level of activation of infected cells increases because the more virions are transferred from infected to uninfected cells during cell-to-cell transmission, the less effectively the treatment is able to inhibit the transmission. The basic reproduction number R_0 of the model is shown to determine the existence and stability of the equilibria. Using the principal spectral theory and comparison principle, we show that the infection-free equilibrium is locally and globally asymptotically stable when R_0 is less than one. By constructing Lyapunov functional, we prove that the infected equilibrium is globally asymptotically stable when R_0 is greater than one. Numerical investigation shows that even when treatment can completely block cell-free virus infection, virus can still persist due to cell-to-cell transmission. The random switch between infected cells with different activation levels can also contribute to the replenishment of the latent reservoir, which is considered as a major barrier to viral eradication. This study provides a new modeling framework to study the observations, such as the low viral load persistence, extremely slow decay of latently infected cells and transient viral load measurements above the detection limit, in HIV-infected patients during suppressive antiretroviral therapy.

HIV Infection Dynamics with Broadly Neutralizing Antibodies and CTL Immune Response

The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission

Modeling Within-Host Viral Dynamics: the Role of CTL Immune Responses in the Evolution of Drug Resistance

Viral dynamics model with CTL immune response incorporating antiretroviral therapy

Mathematical analysis of an HIV model with latent reservoir, delayed CTL immune response and immune impairment

Dynamics of a New HIV Model with the Activation Status of Infected Cells

Analysis of an HIV Model with Immune Responses and Cell-to-Cell Transmission

Modeling the Effect of Reactive Oxygen Species and CTL Immune Response on HIV Dynamics

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

A mathematical model for HIV dynamics with multiple infections: implications for immune escape

A New Mathematical Model for Assessing Therapeutic Strategies for HIV Infection

Modeling HIV Dynamics Under Combination Therapy with Inducers and Antibodies

Hiv-1 Population Dynamics in Vivo: Implications for Pathogenesis, Effect of Cytokine and Therapy Strategy

Human immunodeficiency virus (HIV) dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte (CTL) escape mutants

Stability analysis for a HIV model with cell-to-cell transmission, two immune responses and induced apoptosis

MODELING THE EFFECT OF ACTIVATION OF CD4+T CELLS ON HIV DYNAMICS

Dynamics Analysis and Simulation of a Modified HIV Infection Model with a Saturated Infection Rate.

Modeling virus-stimulated proliferation of CD4+ T-cell, cell-to-cell transmission and viral loss in HIV infection dynamics

A Piecewise Model of Virus-Immune System with Two Thresholds

Modeling of HIV-1 Infection: Insights to the Role of Monocytes/Macrophages, Latently Infected T4 Cells, and HAART Regimes

HIV Infection Dynamics and Viral Rebound: Modeling Results from Humanized Mice.